We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$8.27B
AUM Growth
+$555M
Cap. Flow
+$466M
Cap. Flow %
5.63%
Top 10 Hldgs %
27.66%
Holding
409
New
6
Increased
188
Reduced
153
Closed
18

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$98.2M
2
AMGN icon
Amgen
AMGN
+$71.4M
3
TXN icon
Texas Instruments
TXN
+$39.2M
4
MMM icon
3M
MMM
+$22M
5
TFC icon
Truist Financial
TFC
+$19.2M

Top Sells

Rank Stock Value
1
SJM icon
J.M. Smucker
SJM
+$33M
2
KMB icon
Kimberly-Clark
KMB
+$32.7M
3
O icon
Realty Income
O
+$26.9M
4
JCI icon
Johnson Controls International
JCI
+$20.1M
5
ABBV icon
AbbVie
ABBV
+$19.7M

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Technology 16.64%
3 Consumer Staples 15.19%
4 Financials 12.88%
5 Industrials 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAP icon
251
SAP
SAP
$230B
$891K 0.01%
9,751
+738
+8% +$63.4K
RAVN
252
DELISTED
Raven Industries Inc
RAVN
$865K 0.01%
37,566
+17,695
+89% +$381K
ATO icon
253
Atmos Energy
ATO
$28.7B
$862K 0.01%
11,570
+535
+5% +$41.2K
MON
254
DELISTED
Monsanto Co
MON
$862K 0.01%
8,438
-6,254
-43% -$656K
CHE icon
255
Chemed
CHE
$7.18B
$854K 0.01%
6,055
DHR icon
256
Danaher
DHR
$141B
$849K 0.01%
12,225
-3,924
-24% -$278K
MLAB icon
257
Mesa Laboratories
MLAB
$565M
$838K 0.01%
7,330
+2,135
+41% +$243K
NATI
258
DELISTED
National Instruments Corp
NATI
$829K 0.01%
29,200
+2,681
+10% +$75.3K
DOX icon
259
Amdocs
DOX
$6.28B
$822K 0.01%
14,208
+325
+2% +$19.1K
LFUS icon
260
Littelfuse
LFUS
$11.7B
$817K 0.01%
6,341
+3,025
+91% +$371K
HDB icon
261
HDFC Bank
HDB
$122B
$806K 0.01%
44,840
-1,000
-2% -$17.6K
PEGA icon
262
Pegasystems
PEGA
$5.21B
$796K 0.01%
54,018
+4,980
+10% +$67.5K
MATW icon
263
Matthews International
MATW
$863M
$786K 0.01%
12,933
+1,180
+10% +$70.9K
GLD icon
264
SPDR Gold Trust
GLD
$138B
$779K 0.01%
6,199
-8
-0.1% -$1.02K
MATV icon
265
Mativ Holdings
MATV
$644M
$768K 0.01%
19,910
+1,165
+6% +$44.4K
SU icon
266
Suncor Energy
SU
$72.4B
$764K 0.01%
27,508
+53
+0.2% +$1.45K
GSK icon
267
GSK
GSK
$104B
$747K 0.01%
13,865
-612
-4% -$33.6K
UFPI icon
268
UFP Industries
UFPI
$5.19B
$739K 0.01%
22,515
+1,965
+10% +$68.2K
SI
269
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$739K 0.01%
6,295
-309
-5% -$36.3K
CAT icon
270
Caterpillar
CAT
$395B
$738K 0.01%
8,316
-48
-0.6% -$3.93K
SON icon
271
Sonoco
SON
$5.64B
$733K 0.01%
13,870
+685
+5% +$35.3K
SNN icon
272
Smith & Nephew
SNN
$12.5B
$730K 0.01%
22,260
LMAT icon
273
LeMaitre Vascular
LMAT
$1.85B
$728K 0.01%
36,730
+3,350
+10% +$58.5K
MNRO icon
274
Monro
MNRO
$388M
$721K 0.01%
11,785
-4,460
-27% -$270K
CVG
275
DELISTED
Convergys
CVG
$719K 0.01%
23,648

Similar funds

Bahl & Gaynor's Q3 2016 Portfolio in Review

As of Q3 2016, Bahl & Gaynor held 409 positions worth $8.27B, up 7.2% from $7.71B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bahl & Gaynor deployed $466M of net new capital in Q3 2016, opening 6 new positions and adding to 188 existing holdings. Its largest new stake was Dollar General: 145,451 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was J.M. Smucker, an estimated $33M trimmed.

  • Bahl & Gaynor's largest Q3 2016 buy was Dollar General: 145,451 shares worth $10.2M.
  • Bahl & Gaynor added most to Abbott in Q3 2016, an estimated $98.2M increase.
  • Bahl & Gaynor's biggest Q3 2016 reduction was J.M. Smucker, cutting an estimated $33M.
  • Bahl & Gaynor fully exited Ross Stores in Q3 2016, selling an estimated $864K.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $8.27B portfolio in Q3 2016.
  • Bahl & Gaynor opened 6 new positions and closed 18 in Q3 2016.
  • Bahl & Gaynor's portfolio value rose 7.2% quarter-over-quarter to $8.27B.

Based on Bahl & Gaynor's 13F filing for Q3 2016, filed 7 Nov 2016.